Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, May 2nd. The business services provider reported $0.57 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.87 by ($0.30). The firm had revenue of $830.10 million during the quarter, compared to analysts’ expectations of $866.19 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. Stericycle’s revenue for the quarter was down 7.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.21 earnings per share.
A number of other equities research analysts have also weighed in on the stock. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Tuesday, March 26th. Barrington Research dropped their price objective on shares of Stericycle from $64.00 to $55.00 and set an “outperform” rating on the stock in a report on Monday, March 11th. BMO Capital Markets boosted their price objective on shares of Stericycle to $50.00 and gave the company a “market perform” rating in a report on Friday, March 22nd. Zacks Investment Research lowered shares of Stericycle from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 7th. Finally, Robert W. Baird downgraded shares of Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 target price for the company. in a research report on Wednesday, April 17th. Five research analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $59.00.
Shares of SRCL remained flat at $$48.04 during trading hours on Tuesday. 327,926 shares of the stock were exchanged, compared to its average volume of 1,059,878. The stock has a market cap of $4.34 billion, a P/E ratio of 10.80, a PEG ratio of 1.89 and a beta of 1.21. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.02 and a quick ratio of 1.02. Stericycle has a 12-month low of $34.36 and a 12-month high of $71.43. The business has a 50-day moving average price of $46.67.
Several institutional investors have recently modified their holdings of the business. Vanguard Group Inc raised its position in shares of Stericycle by 2.6% in the third quarter. Vanguard Group Inc now owns 9,015,988 shares of the business services provider’s stock worth $529,058,000 after acquiring an additional 228,533 shares during the period. BlackRock Inc. raised its position in shares of Stericycle by 40.9% in the fourth quarter. BlackRock Inc. now owns 7,616,828 shares of the business services provider’s stock worth $279,461,000 after acquiring an additional 2,210,880 shares during the period. Clarkston Capital Partners LLC raised its position in shares of Stericycle by 2.7% in the first quarter. Clarkston Capital Partners LLC now owns 4,106,285 shares of the business services provider’s stock worth $223,464,000 after acquiring an additional 107,400 shares during the period. Iridian Asset Management LLC CT acquired a new position in shares of Stericycle during the 1st quarter worth about $168,624,000. Finally, FMR LLC raised its position in shares of Stericycle by 31.8% during the 1st quarter. FMR LLC now owns 2,632,945 shares of the business services provider’s stock worth $143,285,000 after purchasing an additional 635,344 shares during the last quarter. Institutional investors and hedge funds own 96.52% of the company’s stock.
In related news, Director Mark C. Miller sold 260,314 shares of the business’s stock in a transaction on Tuesday, April 9th. The shares were sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the completion of the transaction, the director now directly owns 325,848 shares in the company, valued at $18,631,988.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.30% of the company’s stock.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.